Buflomedil

Edit

Aug. 15, 2013 - China Pharma Holdings, Inc. Reports Second Quarter 2013 Financial Results (China Pharma Holdings Inc)

noodls

15 Aug 2013

(Source. China Pharma Holdings Inc) China Pharma Holdings, Inc. Reports Second Quarter 2013 Financial Results. HAIKOU CITY, China, August 15, 2013 ‐ China Pharma Holdings, Inc. (NYSE MKT ... Second Quarter Highlights ...  The Company entered an eight‐year construction loan facility with a bank on June 21, 2013 ... The CFDA issued a nationwide notice for the cessation of the production, sale and use of Buflomedil effective immediately in March 2013....(size: 17.0Kb)

Edit

China Pharma Holdings, Inc. Reports Second Quarter 2013 Financial Results

Seeking Alpha

15 Aug 2013

HAIKOU CITY, China, Aug. 15, 2013 /PRNewswire/ -- China Pharma Holdings, Inc ... Second Quarter Highlights Revenue decreased 45% to $8.0 million in the second quarter of 2013 from $14.6 million in the second quarter of 2012 ... This strategy temporarily impacts our sales in the current period." Ms ... The CFDA issued a nationwide notice for the cessation of the production, sale and use of Buflomedil effective immediately in March 2013 ... Contact . ... - ... ....(size: 21.2Kb)

Edit

China Pharma Holdings, Inc. Reports First Quarter 2013 Financial Results

Stockhouse

15 May 2013

This decrease was primarily due to our continued tightened marketing strategy as well as the cessation of our product Buflomedil. In March 2013, the China Food and Drug Administration ("CFDA") issued a nationwide notice (the "CFDA Notice") for the cessation of the production, sale and use of Buflomedil effective immediately ... notice on Buflomedil....(size: 15.9Kb)

Edit

May 15, 2013 - China Pharma Holdings, Inc. Reports First Quarter 2013 Financial Results (China Pharma Holdings Inc)

noodls

15 May 2013

This decrease was primarily due to our continued tightened marketing strategy as well as the cessation of our product Buflomedil. In March 2013, the China Food and Drug Administration ("CFDA") issued a nationwide notice (the "CFDA Notice") for the cessation of the production, sale and use of Buflomedil effective immediately ... As a result of the CFDA notice ceasing production of Buflomedil, we have net operating loss carry forwards of....(size: 17.9Kb)

Edit

20pc of French bottled water has traces of pesticides and drugs

South China Morning Post

26 Mar 2013

They are sold as being cleaner, healthier and purer than the water that spouts from the average French tap ... Traces of the prescription drugs buflomedil and naftidrofuryl, known as vasodilators and used to dilate arteries in those suffering with high blood pressure, were found in Hepar and Saint Armand mineral waters. Molecules from pesticides banned in 2001 were found in bottles of Vittel, Volvic, Cora and Cristaline ... ....(size: 2.1Kb)

Edit

One in five French bottled waters contain 'drugs or pesticides'

The Guardian

25 Mar 2013

Researchers analysed 47 widely available brands, and discovered 10 were contaminated with miniscule amounts. Traces of pesticides and prescription drugs have been found in some brands of bottled water in France. Photograph ... Traces of the prescription drugs buflomedil and naftidrofuryl, known as vasodilators and used to dilate arteries in those suffering with high blood pressure, were found in Hepar and Saint Armand mineral waters ... ....(size: 3.5Kb)

Edit

One in five French bottled waters 'contain drugs or pesticides'

The Guardian

25 Mar 2013

Researchers analysed 47 widely available brands, and discovered 10 were contaminated with miniscule amounts. Traces of pesticides and prescription drugs have been found in some brands of bottled water in France. Photograph ... Traces of the prescription drugs buflomedil and naftidrofuryl, known as vasodilators and used to dilate arteries in those suffering from high blood pressure, were found in Hepar and Saint Armand mineral waters ... ....(size: 3.5Kb)

Edit

China Pharma Holdings, Inc. Reports Third Quarter 2012 Financial Results

Stockhouse

15 Nov 2012

HAIKOU CITY, China, Nov. 15, 2012 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT. CPHI) ("China Pharma" or the "Company"), a specialty pharmaceuticals company in China, today announced financial results for the quarter ended September 30, 2012 ... Third Quarter of FY2012 Results of Operations ... Shortfalls in sales of Ozagrel Sodium for Injection and Buflomedil Hydrochloride were major contributors for the decline ... Nine months Results ... -....(size: 14.9Kb)

Edit

Nov. 15, 2012 - China Pharma Holdings, Inc. Reports Third Quarter 2012 Financi (China Pharma Holdings Inc)

noodls

15 Nov 2012

China Pharma Holdings, Inc. Reports. Third Quarter 2012 Financial Results. HAIKOU CITY, China, November 15, 2012 - China Pharma Holdings, Inc. (NYSE MKT. CPHI) ("China Pharma" or the "Company"), a specialty pharmaceuticals company in China, today announced financial results for the quarter ended September 30, 2012 ... 2012. Shortfalls in sales of Ozagrel Sodium for Injection and Buflomedil Hydrochloride were major contributors for the decline....(size: 20.4Kb)

Edit

Medical Marijuana Inc. and Canipa Holdings Drive Dixie X and CanChew Gum Toward EU Marketing Approval And Clinical Development

PR Newswire

01 Aug 2012

 . , Aug. 1, 2012 /PRNewswire/ -- Medical Marijuana Inc. (OTC ... Approval Process ... We expect preliminary approval in 60 days and final approval 30 days after ... Pending Clinical Studies ... Recently the European Medicines Agency has recommended a suspension of all buflomedil-containing medicines due to safety concerns. Some pain medications contain buflomedil, a vaso-active agent, which has an effect on circulation. ... Market Size ... P....(size: 13.5Kb)

Make changes yourself !

buflomédil , nimésulide , vinflunine : retrait demandé